Total Payments
$9,405
2024 Payments
$283.83
Companies
32
Transactions
365
Medicare Patients
801
Medicare Billing
$42,779
Payment Breakdown by Category
Food & Beverage$9,366 (99.6%)
Education$39.51 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,366 | 355 | 99.6% |
| Education | $39.51 | 10 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,744 | 53 | $0 (2023) |
| Lilly USA, LLC | $837.54 | 30 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $790.73 | 16 | $0 (2020) |
| Amgen Inc. | $765.61 | 33 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $626.62 | 14 | $0 (2019) |
| Allergan, Inc. | $516.23 | 30 | $0 (2020) |
| Novo Nordisk Inc | $447.04 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $426.65 | 27 | $0 (2020) |
| GlaxoSmithKline, LLC. | $353.01 | 21 | $0 (2021) |
| Amarin Pharma Inc. | $330.24 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $283.83 | 9 | Gilead Sciences, Inc. ($196.73) |
| 2023 | $157.60 | 7 | Novartis Pharmaceuticals Corporation ($31.04) |
| 2022 | $514.72 | 11 | Novo Nordisk Inc ($176.98) |
| 2021 | $591.23 | 23 | AbbVie Inc. ($260.46) |
| 2020 | $665.24 | 28 | Allergan, Inc. ($237.38) |
| 2019 | $2,333 | 90 | AstraZeneca Pharmaceuticals LP ($584.90) |
| 2018 | $1,935 | 80 | AstraZeneca Pharmaceuticals LP ($374.03) |
| 2017 | $2,925 | 117 | AstraZeneca Pharmaceuticals LP ($591.67) |
All Payment Transactions
365 individual payment records from CMS Open Payments — Page 5 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Neuroscience | ||||||
| 09/05/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $91.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Bone Health | ||||||
| 08/22/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 08/21/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Neuroscience | ||||||
| 08/16/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: Neuroscience | ||||||
| 08/14/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $123.18 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/05/2019 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $85.79 | General |
| Category: Allergy/Immunology | ||||||
| 08/01/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: DIABETES | ||||||
| 07/31/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Bone Health | ||||||
| 07/29/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: KRYSTEXXA | ||||||
| 07/27/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2019 | Lilly USA, LLC | — | Education | In-kind items and services | $8.35 | General |
| 07/10/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $102.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2019 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) (Biological), Fluad | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Vaccines | ||||||
| 07/02/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2019 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Diabetes | ||||||
| 06/20/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: KRYSTEXXA | ||||||
| 06/13/2019 | Allergan Inc. | LASTACAFT (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/10/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $25.97 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 170 | 218 | $28,076 | $8,705 |
| 2022 | 7 | 187 | 256 | $32,089 | $10,207 |
| 2021 | 8 | 220 | 287 | $36,161 | $12,551 |
| 2020 | 8 | 224 | 289 | $36,448 | $11,315 |
Total Patients
801
Total Services
1,050
Medicare Billing
$42,779
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 66 | $9,900 | $3,824 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 31 | $7,440 | $2,152 | 28.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 28 | $1,540 | $948.64 | 61.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 13 | $1,300 | $931.70 | 71.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 18 | $576.00 | $348.32 | 60.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 33 | $2,970 | $260.68 | 8.8% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 25 | 29 | $4,350 | $240.87 | 5.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 86 | $12,900 | $5,513 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 30 | $7,200 | $1,607 | 22.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 35 | $1,925 | $1,233 | 64.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,400 | $959.56 | 68.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 21 | 27 | $864.00 | $442.67 | 51.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 24 | 34 | $5,100 | $227.88 | 4.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 30 | 30 | $2,700 | $224.42 | 8.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 94 | $14,100 | $6,692 | 47.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 36 | $8,640 | $2,358 | 27.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 29 | 41 | $2,255 | $1,450 | 64.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 11 | 11 | $1,100 | $717.86 | 65.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 40 | 41 | $3,690 | $402.77 | 10.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 26 | 35 | $5,250 | $375.78 | 7.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 16 | 18 | $576.00 | $330.90 | 57.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $550.00 | $224.18 | 40.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 58 | 101 | $15,150 | $5,505 | 36.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 41 | $9,840 | $2,311 | 23.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 29 | 36 | $1,980 | $1,140 | 57.6% |
About Dr. Jacob George, MD
Dr. Jacob George, MD is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679674717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob George, MD has received a total of $9,405 in payments from pharmaceutical and medical device companies, with $283.83 received in 2024. These payments were reported across 365 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,366).
As a Medicare-enrolled provider, George has provided services to 801 Medicare beneficiaries, totaling 1,050 services with total Medicare billing of $42,779. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Brooklyn, NY
- Active Since 09/25/2006
- Last Updated 05/27/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679674717
Products in Payments
- FARXIGA (Drug) $995.20
- INVOKANA (Drug) $615.01
- TRULICITY (Drug) $571.40
- SOLIQUA (Drug) $360.83
- TOUJEO (Drug) $349.22
- Vascepa (Drug) $330.24
- Ozempic (Drug) $305.71
- JARDIANCE (Drug) $282.30
- BEVESPI AEROSPHERE (Drug) $276.12
- UBRELVY (Drug) $262.42
- Aimovig (Biological) $247.59
- ENTRESTO (Drug) $243.24
- VRAYLAR (Drug) $236.85
- LINZESS (Drug) $236.66
- KRYSTEXXA (Drug) $230.16
- Repatha (Biological) $202.32
- BYDUREON (Drug) $199.47
- ANORO (Drug) $175.19
- CHANTIX (Drug) $163.70
- BREZTRI (Drug) $153.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Internal Medicine $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Internal Medicine $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Internal Medicine $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Internal Medicine $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Internal Medicine $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Internal Medicine $159,733